Regardless of whether you're willing to take on risk or not and whether you're willing to be patient and hold a stock for years, top Canadian cannabis retailer Tilray Brands (NASDAQ: TLRY) just isn't a company worth taking a chance on. Tilray's latest earnings results only solidify why this is an all-around bad buy. Tilray reported its third-quarter earnings this month, and its net loss for the period ending Feb. 28 was a mammoth $1.2 billion. Read More...
Bloomberg
Engaged Couples Issue Verdict on Bed Bath & Beyond
(Bloomberg) — While Bed Bath & Beyond Inc. executives insist the troubled retailer has a brighter future, many engaged couples have already issued their verdict: They don’t think the company will survive. Most Read from BloombergBud Light Kicked a Hornet’s Nest and Ran AwayIn Morgan Stanley CEO Race, Wealth Boss Emerges as One to WatchMerck-Moderna Vaccine Helps Keep Patients Free From Skin CancerFuel That Powers the Global Economy Is Flashing Recession SignsA $300,000 Salary Feels Like $100,00
Add Comment